HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrei Iagaru Selected Research

BAY 86-7548

12/2022Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer.
1/2022Reduced Acquisition Time per Bed Position for PET/MRI Using 68Ga-RM2 or 68Ga-PSMA-11 in Patients With Prostate Cancer: A Retrospective Analysis.
1/2020Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements.
1/2018Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrei Iagaru Research Topics

Disease

45Neoplasms (Cancer)
12/2022 - 09/2006
22Prostatic Neoplasms (Prostate Cancer)
12/2022 - 12/2015
14Neoplasm Metastasis (Metastasis)
12/2022 - 10/2006
8Thyroid Neoplasms (Thyroid Cancer)
12/2018 - 09/2006
6Breast Neoplasms (Breast Cancer)
01/2020 - 01/2007
5Melanoma (Melanoma, Malignant)
10/2021 - 01/2008
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015 - 11/2008
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 06/2016
4Glioma (Gliomas)
12/2021 - 09/2018
3Adenocarcinoma
12/2022 - 08/2019
3Anaplastic Thyroid Carcinoma
12/2018 - 09/2015
3Sarcoma (Soft Tissue Sarcoma)
09/2015 - 10/2006
3Papillary Thyroid Cancer
02/2015 - 09/2006
3Lymphoma (Lymphomas)
12/2010 - 03/2008
2Lymphatic Metastasis
12/2022 - 01/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2022 - 09/2020
2Glioblastoma (Glioblastoma Multiforme)
12/2021 - 11/2015
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021 - 11/2014
2Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2016 - 12/2009
2Carcinoma (Carcinomatosis)
09/2015 - 12/2009
2Disease Progression
08/2012 - 11/2008
1Hyperthyroidism
01/2022
1Carcinogenesis
01/2022
1Hypoalbuminemia
01/2022
1Neuroinflammatory Diseases
11/2021
1Hypoxia (Hypoxemia)
11/2021
1Leiomyosarcoma
05/2021
1Idiopathic Pulmonary Fibrosis
10/2019
1Lung Diseases (Lung Disease)
10/2019
1Renal Cell Carcinoma (Grawitz Tumor)
07/2019
1Meningioma (Meningiomas)
09/2018

Drug/Important Bio-Agent (IBA)

20Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2021 - 10/2006
13Glucose (Dextrose)FDA LinkGeneric
05/2021 - 09/2006
12RadiopharmaceuticalsIBA
12/2022 - 12/2011
8AntigensIBA
12/2022 - 04/2017
7Peptides (Polypeptides)IBA
12/2022 - 11/2014
6Bombesin Receptors (Bombesin Receptor)IBA
12/2022 - 04/2016
4IntegrinsIBA
12/2022 - 06/2016
4BAY 86-7548IBA
12/2022 - 01/2018
4BombesinIBA
01/2020 - 04/2017
4aspartic acid glycine arginineIBA
07/2019 - 11/2014
4IodineIBA
12/2014 - 03/2007
3gallium 68 PSMA-11IBA
12/2022 - 01/2018
3AcidsIBA
08/2022 - 01/2015
3Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
04/2017 - 12/2011
3Technetium Tc 99m MedronateIBA
12/2015 - 09/2008
3arginyl-glycyl-aspartic acidIBA
11/2015 - 11/2014
2Cystine (L-Cystine)IBA
12/2022 - 10/2019
2Cystine-Knot MiniproteinsIBA
12/2022 - 10/2019
2Radium-223IBA
03/2022 - 01/2018
2Choline (Choline Chloride)IBA
03/2022 - 01/2020
2Radioisotopes (Radionuclides)IBA
01/2022 - 01/2022
2Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022 - 10/2019
2diazobenzenesulfonic acid (DASA)IBA
12/2021 - 01/2020
2Biological ProductsIBA
11/2021 - 01/2020
2Deoxyglucose (2 Deoxy D glucose)IBA
11/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
11/2020 - 08/2012
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
06/2016 - 01/2015
2FluorineIBA
11/2015 - 11/2014
264Cu-DOTA-rituximabIBA
01/2015 - 10/2012
1Gallium-68IBA
08/2022
1Lutetium-177IBA
08/2022
1pyridineIBA
08/2022
1Peptide Receptors (Peptide Receptor)IBA
01/2022
1CreatinineIBA
01/2022
1Pyruvate KinaseIBA
12/2021
1Amino AcidsFDA Link
11/2021
1AntibodiesIBA
10/2021
1Programmed Cell Death 1 ReceptorIBA
10/2021
1HexosaminesIBA
05/2021
1Transaminases (Aminotransferases)IBA
05/2021
1EnzymesIBA
05/2021
12- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA
01/2021
1Yttrium-90IBA
01/2021
1Immune Checkpoint InhibitorsIBA
11/2020
1GastrinsIBA
01/2020
1FluoridesIBA
01/2020
1SiliconIBA
01/2020
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1MucinsIBA
01/2020
1Molecular Probes (Molecular Probe)IBA
01/2020
1SodiumIBA
01/2020
11- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
10/2019
1Lactic Acid (Lactate)FDA LinkGeneric
10/2019
1gallium Ga 68 dotatateIBA
10/2019
1Pyruvic Acid (Pyruvate)IBA
10/2019
1FPP(RGD)2IBA
07/2019
1Pharmaceutical PreparationsIBA
01/2019

Therapy/Procedure

29Therapeutics
12/2022 - 10/2006
4Radiotherapy
01/2022 - 01/2009
4Immunotherapy
01/2021 - 12/2010
3Prostatectomy (Retropubic Prostatectomy)
12/2022 - 01/2018
3Aftercare (After-Treatment)
09/2020 - 09/2008
3Drug Therapy (Chemotherapy)
01/2020 - 01/2008
3Radioimmunotherapy
12/2010 - 03/2008
2Castration
08/2022 - 01/2018
2Precision Medicine
01/2022 - 01/2018
1Microspheres (Microsphere)
01/2021
1Hematopoietic Stem Cell Transplantation
01/2021